A detailed history of Swiss National Bank transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 75,700 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,700
Previous 66,000 14.7%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
N/A
9,700 Added 14.7%
75,700 $0
Q4 2023

Feb 06, 2024

SELL
N/A
-16,300 Reduced 19.81%
66,000 $0
Q2 2023

Aug 09, 2023

BUY
N/A
82,300 New
82,300 $0
Q4 2021

Feb 08, 2022

SELL
$6.03 - $11.67 $139,293 - $269,577
-23,100 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$24.71 - $44.28 $570,801 - $1.02 Million
23,100 New
23,100 $714,000

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.